跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 451 条关于
“apolipoprotein C3”
全部
451
临床试验
170
药物
37
机构
0
资讯
244
10个月前
Rona Therapeutics' RN0361 siRNA Demonstrates 93% ApoC3 Reduction in Phase 1 Trial for Severe Hypertriglyceridemia
5个月前
Triglyceride-Lowering Drug Olezarsen Fails to Reduce Arterial Plaque Despite 60% Triglyceride Reduction
去年
Arrowhead Pharmaceuticals Advances Two Breakthrough RNAi Therapeutics into Clinical Trials
2年前
ApoA-I Infusions Show Promise in Reducing Cardiovascular Events Post-MI, Especially in Patients with Lower LDL-C
去年
Arrowhead's ARO-C3 Shows Promising Results in IgA Nephropathy Trial with 89% Reduction in C3 Levels
上个月
Ancient Immune Protein C3 Boosts Cancer Immunotherapy When Produced Inside Tumors
去年
Novartis' Fabhalta Demonstrates Sustained Benefits in Phase III Trial for C3 Glomerulopathy
去年
Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy
去年
Roche Launches Elecsys PRO-C3 Test for Precise Liver Fibrosis Assessment in MASLD Patients
去年
Novartis' Fabhalta Shows Sustained Efficacy in C3 Glomerulopathy at 12 Months
第 1 页,共 25 页
上一页
下一页